🚀 VC round data is live in beta, check it out!
Oneness Biotech Valuation Multiples
Discover revenue and EBITDA valuation multiples for Oneness Biotech and similar public comparables like Bioage Labs, SpyGlass Pharma, Clarity Pharmaceuticals, ARS Pharmaceuticals and more.
Oneness Biotech Overview
About Oneness Biotech
Oneness Biotech Co Ltd is engaged in the research and development of new drugs, the sale of pharmaceutical products and health products, and other related businesses. It focuses on developing drugs for the treatment of chronic skin and immune diseases. The company's product portfolio comprises FESPIXON cream, for the treatment of diabetic foot ulcers, and also has various other product candidates in its development pipeline, such as FB825, FB704A, SNS812, OB318, and others. Along with its subsidiaries, the company operates in the following reportable segments: New drug research and development, which derives maximum revenue, and the Agricultural products cultivation segment.
Founded
2008
HQ
Employees
N/A
Website
Sectors
Financials (FY)
EV
$654M
Oneness Biotech Financials
Oneness Biotech reported last fiscal year revenue of $4M and negative EBITDA of ($23M).
In the same fiscal year, Oneness Biotech generated $1M in gross profit, ($23M) in EBITDA losses, and had net loss of ($33M).
Oneness Biotech P&L
In the most recent fiscal year, Oneness Biotech reported revenue of $4M and EBITDA of ($23M).
Oneness Biotech expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $4M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $1M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 31% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($23M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (552%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (619%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($33M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (809%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Oneness Biotech Stock Performance
Oneness Biotech has current market cap of $826M, and enterprise value of $654M.
Market Cap Evolution
Oneness Biotech's stock price is $1.72.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $654M | $826M | -2.2% | XXX | XXX | XXX | $-0.07 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialOneness Biotech Valuation Multiples
Oneness Biotech trades at 159.7x EV/Revenue multiple, and (28.9x) EV/EBITDA.
Oneness Biotech Financial Valuation Multiples
As of April 19, 2026, Oneness Biotech has market cap of $826M and EV of $654M.
Equity research analysts estimate Oneness Biotech's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Oneness Biotech has a P/E ratio of (25.0x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $826M | XXX | $826M | XXX | XXX | XXX |
| EV (current) | $654M | XXX | $654M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 159.7x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (28.9x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (25.8x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 517.2x | XXX | XXX | XXX |
| P/E | — | XXX | (25.0x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (42.4x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Oneness Biotech Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Oneness Biotech Margins & Growth Rates
Oneness Biotech's revenue in the last fiscal year grew by 9%.
Oneness Biotech Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (552%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 4% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 50% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 130% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 469% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 650% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Oneness Biotech Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Oneness Biotech | XXX | XXX | XXX | XXX | XXX | XXX |
| Bioage Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| SpyGlass Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Clarity Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| ARS Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| Vor Biopharma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Oneness Biotech M&A Activity
Oneness Biotech acquired XXX companies to date.
Last acquisition by Oneness Biotech was on XXXXXXXX, XXXXX. Oneness Biotech acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Oneness Biotech
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialOneness Biotech Investment Activity
Oneness Biotech invested in XXX companies to date.
Oneness Biotech made its latest investment on XXXXXXXX, XXXXX. Oneness Biotech invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Oneness Biotech
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Oneness Biotech
| When was Oneness Biotech founded? | Oneness Biotech was founded in 2008. |
| Where is Oneness Biotech headquartered? | Oneness Biotech is headquartered in Taiwan. |
| Is Oneness Biotech publicly listed? | Yes, Oneness Biotech is a public company listed on Taipei Exchange. |
| What is the stock symbol of Oneness Biotech? | Oneness Biotech trades under 4743 ticker. |
| When did Oneness Biotech go public? | Oneness Biotech went public in 2011. |
| Who are competitors of Oneness Biotech? | Oneness Biotech main competitors are Bioage Labs, SpyGlass Pharma, Clarity Pharmaceuticals, ARS Pharmaceuticals. |
| What is the current market cap of Oneness Biotech? | Oneness Biotech's current market cap is $826M. |
| What is the current revenue of Oneness Biotech? | Oneness Biotech's last fiscal year revenue is $4M. |
| What is the current EV/Revenue multiple of Oneness Biotech? | Current revenue multiple of Oneness Biotech is 159.7x. |
| Is Oneness Biotech profitable? | No, Oneness Biotech is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.